China's tourism revival: Visa-free entry to over 70 countries fuels foreign arrivals; travel firms report booming post-Covid recovery
China has significantly expanded its visa-free entry policy, allowing citizens from 74 countries to visit for up to 30 days without a visa.
The move, aimed at reviving inbound tourism and stimulating the economy, has led to a sharp rise in foreign arrivals.
Since late 2023, Beijing has steadily expanded the policy, allowing short-term visits of up to 30 days for travellers from much of Europe, Asia, Latin America and the Middle East.
As per the Associated Press (AP), more than 20 million people entered China without a visa in 2024, more than doubling the previous year's figure and accounting for nearly a third of all foreign arrivals.
'This really helps people to travel because it is such a hassle to apply for a visa,' said Georgi Shavadze, a tourist visiting Beijing from Austria, as cited by AP.
Others, like Norwegian Øystein Sporsheim, welcomed the relief from multiple embassy visits when travelling with children.
While the majority of footfall at tourist spots remains domestic, the landscape is rapidly shifting. Gao Jun, an English-speaking tour guide in Beijing, was quoted by AP saying that he was 'overwhelmed with tours' and had launched a training programme for aspiring guides to meet growing demand.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Cervecería Nacional CFD: Calcula cuánto podrías ganar invirtiendo solo $100
Empieza a invertir hoy
Empieza ahora
Undo
Tour companies are also seeing a revival, Jenny Zhao of boutique travel agency WildChina said business was up 50% from pre-pandemic levels, with European travellers now making up 15–20% of clients, a steep rise from under 5% in 2019.
Shanghai, one of China's top gateways, saw 2.6 million overseas visits in the first half of 2025, a 44.8% year-on-year jump, with over half of them entering visa-free, according to local authorities.
As per the South China Morning Post, Pudong International Airport handled 2.37 million foreign entries, topping national rankings. In Beijing, 840,000 of 1.49 million foreign entries were visa-free, while Chengdu saw a 120% rise in such arrivals.
Hainan, which allows visa-free travel for 59 countries, recorded nearly 663,000 foreign entries, 89% under the scheme.
Trip.com Group, a Shanghai-based online travel agency, said bookings for air travel and hotels in China doubled in the first quarter of 2025 compared to the same period last year, with 75% of visitors coming from visa-exempt regions, according to AP.
The policy's reach continues to widen. On July 16, Azerbaijan will become the 75th country to benefit. About two-thirds of the nations currently included are under a one-year trial period.
For those outside the scheme, including travellers from the US, Canada and the UK, China offers a 10-day visa-free transit option, provided the journey involves onward travel to a third country.
This option applies at 60 designated ports of entry.
James Liang, chairman of leading travel firm Ctrip, said inbound tourism had already recovered to 70–80% of pre-covid levels and 'could be fully recovered this year,' as quoted by Shanghai outlet The Paper.
'If bottlenecks are tackled,' he added, 'China's inbound tourism could reach the world's top tier in 10 or 20 years.'
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
19 minutes ago
- Time of India
India pharma, healthcare revenue to grow steadily in Q1FY26E; EBITDA margins under pressure: Report
Indian pharma and healthcare sector will witness steady revenue growth in the first quarter of the Financial Year 2026 (Q1FY26E), but concerns loom as EBITDA margins are expected to decline amid rising input costs and pricing pressures, according to a report by HDFC Securities. The report added that the pharma sector firms studied by it may witness a 11 per cent year-on-year (YoY) sales growth, driven by an 11 per cent YoY increase in the India business along with 2 per cent QoQ growth in US sales (+2 per cent YoY). The EBITDA, which stands for Earnings Before Interest, Taxes, Depreciation, and Amortization, is a financial metric used to assess a company's profitability and operational efficiency. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 이 게임은 대부분의 TV 프로그램보다 더 재미있어요 – 게다가 무료예요. Raid: Shadow Legends 플레이하기 Undo The report stated that EBITDA margins for the pharma segment are expected to decrease by 42bps YoY, driven by price erosion in the US and an expected increase in research and development (R&D). The hospital business is projected to grow by 15 per cent YoY, as muted occupancy will be partly supported by steady ARPOB, or Average Revenue Per Occupied Bed, which is a key performance indicator used in the healthcare industry to assess a hospital's financial performance. Live Events India's pharmaceutical market for FY 2023-24 is valued at USD 50 billion, with domestic consumption valued at USD 23.5 billion and exports valued at USD 26.5 billion. The domestic pharma industry is considered to be the world's third-largest by volume and 14th in terms of value of production. With an extremely diversified product base covering generic drugs, bulk drugs, over-the-counter drugs, vaccines, biosimilars, and biologics, the Indian pharmaceutical industry has a strong presence at the global level. According to National Accounts Statistics 2024, published by the Ministry of Statistics and Programme Implementation, total output for industry, i.e., Pharmaceuticals, medicinal and botanical products, is Rs. 4,56,246 crores for FY 2022-23 at constant prices, of which value added is Rs 1,75,583 crores.
Time of India
31 minutes ago
- Time of India
OpenAI CEO Sam Altman: ‘Sorry to be the bearer of bad news, but…'
OpenAI CEO Sam Altman has shared a post on microblogging site X, announcing a delay in the launch of the company's upcoming open-weight AI model. The model was originally scheduled to launch next week. In the post, Altman said the teams needs more time to carry out safety tests and closely review areas that could pose risks. 'We planned to launch our open-weight model next are delaying it,' he wrote, adding 'we need time to run additional safety tests and review high-risk areas…we are not yet sure how long it will take us.' OpenAI is planning to release the model with open weights, meaning developers and researchers will be able to download and use the AI system on their own. In his post, Altman stressed that once the model is out, it can not be taken back and hence makes it important to get everything right before release. He said 'while we trust the community will build great things with this model, once weights are out, they can't be pulled back. this is new for us and we want to get it right.' Altman continued: 'sorry to be the bearer of bad news; we are working super hard!' What is an Open weight AI model Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo by Taboola by Taboola An open-weight model is a type of AI model where the underlying "weights" — the core numerical values that define the model's knowledge and behavior — are shared publicly. These weights are the result of training a model on vast datasets and represent what the model has learned. Unlike models that run only on company servers, open-weight models can be used and modified directly by others. This makes them more flexible for developers, but also raises concerns about how the models might be misused. Lava Storm Play First Look: Best Budget Phone Under Rs 10,000? AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
31 minutes ago
- Time of India
European Commission proposes Russian oil price cap 15% below global price
The European Commission proposed on Friday a floating price cap on Russian oil of 15 per cent below the average market price of crude in the previous three months, EU diplomats said. The European Union and Britain have been pushing the Group of Seven nations to lower the cap for the last two months after a fall in oil futures made the current $60 a barrel level largely irrelevant. Brent crude has since rebounded somewhat, and settled on Friday at $70.36 per barrel. The G7 price cap, aimed at curbing Russia's ability to finance the war in Ukraine, was originally agreed in December 2022. The new floating cap would be revised according to the average price every three months, one of the diplomats added. The EU diplomats, who were not authorized to speak publicly, said technical details of the latest proposal still needed to be discussed, but the idea seemed to assuage concerns of the EU's maritime states - Malta, Greece and Cyprus. Despite repeated attempts from European leaders, the US administration has not agreed to lower the cap, prompting the Europeans to push ahead on their own. The price of Russia's Urals oil remained $2 per barrel below the $60 per barrel limit on Friday. The cap bans trade in Russian crude oil transported by tankers if the price paid was above $60 per barrel and prohibits shipping, insurance and re-insurance companies from handling cargoes of Russian crude around the globe, unless it is sold for less than the price cap. The Commission initially proposed in June to lower the cap from $60 a barrel to $45 a barrel as part of its 18th package of sanctions on Russia. The Kremlin said on Friday it has good experience in tackling challenges such as a floating Russian oil price cap , which could be introduced by the European Union. EU sanctions must be agreed unanimously by member states to be adopted.
